Alternative tumour-specific antigens
Christof C. Smith(Dana-Farber Cancer Institute), Jonathan S. Serody(University of North Carolina at Chapel Hill)
Cited by 350
Related Papers
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
|Nature Medicine|2025|189
Anti–PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T Cells
|The Journal of Immunology|2021|25